Professionals 202 Users Online

Pet Allergy Treatment Market

Market Study on Pet Allergy Treatment: Substantial Revenue Generation from Sales of Antibiotics

Pet Allergy Treatment Market Segmented By Corticosteroids, Antihistamines, Immunotherapy and Antibiotics drug class with allergy type such as Runny nose and Sneezing, Eczema, Dermatitis

Pet Allergy Treatment Market Outlook (2023 to 2033)

The global pet allergy treatment market generated a revenue of US$ 2.1 billion in 2022. As per projections by analysts at Persistence Market Research, the market is set to expand at a CAGR of 6.3% and reach a size of US$ 4.1 billion by the end of 2033.

Allergies in pets, such as dogs and cats, are becoming increasingly common, causing discomfort and health issues. Just like humans, pets can develop allergies to various environmental factors, including pollen, dust mites, certain foods, and more. Symptoms may include itching, sneezing, skin irritations, and digestive problems.

The global pet allergy treatment market is responding to this growing concern by offering a range of treatments, including medications, allergen-specific immunotherapy, and hypoallergenic diets. As pet owners become more aware of their furry companions' allergies, the market is expected to expand to meet the demand for effective and safe solutions to alleviate pet allergy symptoms and improve their overall well-being.

  • By drug class, antibiotics accounted for a market share of 34.8% in 2022.
  • Revenue from pet allergy treatment held 5.3% share of the global animal healthcare market in 2022.

Allergic diseases have a significant prevalence in veterinary practice and have been studied extensively over the years. Intradermal testing and allergen immunotherapy, introduced in the mid-19th century, have played crucial roles in diagnosing and managing allergies in animals. Among these, atopic dermatitis is a focal point of research in veterinary dermatology. While it is a rare disease in dogs, its resemblance to human atopic dermatitis has led to its proposition as a potential model for understanding the human counterpart of the condition. Atopic dermatitis is prevalent among cats as well, but the clinical signs differ from those seen in humans.

Growth of the pet allergy treatment market in the United States can be attributed to the increasing pet ownership trend. A surge in pet ownership has driven higher demand for pet healthcare services, including treatments for allergy relief for pets.

  • The American Pet Products Association's National Pet Owners Survey (2021 to 2022) revealed that 67% of households in the United States own pets, marking a significant increase from 56% in 1988.
  • As spending in the pet sector continues to rise, with a 19% increase from US$ 103.6 billion in 2020 to US$ 123.6 billion in 2022, there is a clear indication of the growing focus on pet health and well-being.

Upward trajectory in pet ownership and associated spending underscores the expanding market for pet allergy treatments in the United States. Increasing number of allergic pets and animals is raising interest in and knowledge of veterinary allergology.

The financial effects of veterinarian care on farm and domestic animals make this possible. Development of component-specific diagnostic techniques and research into certain immunotherapies have been made possible by the identification of new allergens, such as the Culicoides-mediated allergic skin condition in horses.

In veterinary medicine, newer technologies such as in silico-based or wet laboratory methods are increasingly being employed. This is expected to offer fresh perspectives on how pet animals' immune systems work, opening the door to the identification of biomarkers, fresh allergens, diagnostic instruments, and innovative therapy ideas.

Attribute Details
Pet Allergy Treatment Market Size (2023) US$ 2.2 Billion
Projected Market Value (2033) US$ 4.1 Billion
Global Market Growth Rate (2023 to 2033) 6.3% CAGR
Market Share of Top 5 Countries (2022) 57%
Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

What are the Key Developments in the Market for Pet Allergy Treatment?

“Increased Awareness of Animal Allergies and Advancements in Veterinary Allergology”

The market is being driven by a combination of factors that reflect the increasing awareness of allergic diseases in animals and advancements in veterinary allergology. While veterinary allergology has historically lagged behind human allergology, efforts to adapt methodologies and develop reagents specific to animals have led to significant progress in the field.

  • For instance, availability of novel reagents and technologies has enabled the identification of relevant allergens and a deeper understanding of the pathogenesis of allergic diseases in animals, such as dogs and horses.

Growing awareness of allergic diseases in veterinary practice and among pet owners has also played a crucial role in fueling the demand for pet allergy treatments. With a substantial percentage of households having pets as companions, the potential economic impact of pet allergies is significant.

  • In several Western countries such as the United States, Canada, and Australia, more than half (about 60%) of the population live alongside pets as per Scientific Reports (2022). This large population of pets, excluding fish and reptiles, underscores the need for effective treatments to address allergic disorders in animals.

Recognition of veterinary allergology as an important and dedicated discipline has contributed to market growth. The awareness that animals deserve specialized care and treatments for allergic diseases has garnered attention and support from both veterinary practitioners and pet owners. As a result, the market for pet allergy treatments is expected to continue expanding as more resources are invested in research, diagnosis, and therapy for allergic disorders in animals, ultimately enhancing the overall well-being and health of pets.

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

Can Market Growth Be Adversely Affected in Any Way?

“Limited Detection Molecules and Complex Interactions between Immunoglobulin Isotypes”

The market faces obstacles in veterinary allergology, a discipline focused on allergic diseases in animals. Challenges include the limited availability of precisely characterized detection molecules and complex interactions between immunoglobulin isotypes and immune cell receptors in certain animals. However, recent efforts have led to the identification of novel allergens and a deeper understanding of animal-specific pathogenesis of allergic diseases.

Primary obstacles to market growth include limited awareness about pet allergies among pet owners, lack of proper diagnosis and testing facilities, high cost of allergy treatments, and the misconception that pet allergies are only caused by pet hair. Additionally, the stigma associated with giving up pets due to allergies and the challenge of finding effective and safe treatments for severe pet allergies contribute to the obstacles in the demand growth for pet allergy treatments.

Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Country-wise Insights

Why is Demand for Pet Allergy Treatment High in the United States?

“Rising Adoption of Pet Health Insurance and High Prevalence of Pet Allergies”

The United States accounted for 30.9% share of the market in 2022. Growing demand for pet allergy treatment in the United States can be attributed to the increasing awareness and adoption of pet health insurance as a payment method for veterinary services. Prevalence of allergies in pets, including food allergies, is on the rise. Up to 20% of all dogs are expected to develop allergies during their lifetime, with symptoms often appearing between 1 and 2 years of age.

  • As per the Animals Journal (Basel) 2020, adoption of pet health insurance has been increasing in the United States at a CAGR of 14.7% since 2014, due to growing awareness of such schemes through veterinary recommendations.

Rising demand for pet allergy treatment in the United States can be attributed to the increasing number of pet care and product manufacturers in the country. As more people own pets and seek effective solutions for allergies, the market for pet allergy treatment is expanding due to the availability of a variety of products and services catering to pet owners' needs.

How is the Pet Allergy Treatment Industry Evolving in China?

“Increase in Pet Ownership and Development of Smart AI Devices for Pets”

China accounted for 7.6% share of the global market in 2022. Demand for pet allergy treatment in China is increasing due to several factors. The rates of dog and cat ownership have significantly risen in the country, with dog ownership more than doubling and cat ownership quadrupling in just a decade. This surge in pet ownership is driven by changes in the living environment, as more pets are now living indoors with their owners.

China is at the forefront of developing 'smart' devices for pets and utilizing artificial intelligence in the pet product sector, which has led to greater awareness and monitoring of pets' health. Pet owners in China reside in large cities with poor air quality, exposing their pets to airborne pollutants and allergens. As pet ownership continues to grow and more emphasis is placed on pets' well-being, demand for effective pet allergy treatment is expected to increase further in China.

Why is Germany a Key Market for Pet Allergy Treatment Providers?

“Advanced Pet Healthcare Facilitating Early Allergy Diagnosis”

Germany held 7% share of the global market in 2022. Germany’s market growth is influenced by various factors, including geographical variations and veterinary advancements. Germany's diverse climatic and environmental conditions contribute to a wide range of allergens that can affect pets, leading to a higher prevalence of allergies. Additionally, the country's advanced veterinary healthcare system enables early diagnosis and effective treatment of pet allergies, driving the demand for allergy treatment options.

  • According to PLOS ONE 2020, Germany has around 9.4 million dogs, and 20% of veterinary visits are for vaccinations and preventative care.

Pet owners in Germany are increasingly conscious of their pets' well-being and are willing to invest in advanced treatments, contributing to market growth. As veterinary practices continue to evolve and offer innovative solutions, the German market is poised for further expansion.

Sales Team

Sales Team
Client Partner

Let's Connect

Connect me to identify winning opportunities

Ask An Expert
I'm Available

Category-wise Insights

Which Drug Class is Most Widely Adopted for Pet Allergy Treatment?

“High Popularity of Antibiotics Due to Their Effectiveness in Curing Allergy-linked Infections”

By drug class, antibiotics occupied 34.8% share of the global market in 2022. Antibiotics are widely adopted for allergy treatment due to their effectiveness in addressing secondary infections that often accompany allergic reactions in pets.

Pets with allergies may exhibit symptoms such as ear infections or respiratory issues, where antibiotics play a crucial role in managing the underlying infections, alleviating the discomfort and potential complications associated with allergies. There is also substantial use of antihistamines but this mainly depends on each case.

Which Indication is Highly Prevalent in Pets and Accounts for High Demand for Treatment?

“High Demand for Treatment Solutions Targeting Allergic Dermatitis”

By indication, allergic dermatitis accounted for 75.4% share of the global market in 2022. Allergic dermatitis, characterized by skin inflammation and irritation, is a common manifestation of pet skin allergies, causing pets to suffer from itching, scratching, and discomfort.

Pet owners often notice these visible signs of allergic dermatitis. As a result, there is a strong demand for effective treatments to alleviate these symptoms and improve the well-being of pets.

Why Do Dogs Account for High Revenue Generation for Market Players?

“Extensive Dog Ownership and Their High Susceptibility to Allergens”

By pet type, dogs accounted for 51.2% share of the global market in 2022. Dogs are the most widely adopted pets globally. However, dogs are susceptible to various allergens, including pollen, dust mites, and certain foods, resulting in a higher demand for allergy treatment options and leading to a larger customer base seeking treatment for pet skin allergies.

The strong emotional bond between pet owners and their dogs motivates them to invest in their pets' well-being, including managing allergies. The market offers a wide range of allergy treatments tailored specifically for dogs, driving significant revenue in the pet allergy testing and treatment space.

Why is the Oral Route Widely Preferred for Administration of Allergy Medications?

“Convenient Integration and Effective Allergy Relief Associated with Oral Medications”

The oral administration route accounted for a 65.7% share of the global market in 2022. Oral treatments, such as allergy medications and immune-modulating therapies, offer pet owners a simple and stress-free way to administer treatment to their furry companions.

Unlike other methods that may require injections or topical applications, oral treatments can be easily incorporated into a pet's daily routine, making compliance more likely. Further, oral treatments have shown promising results in alleviating allergy symptoms, including itching, inflammation, and respiratory issues, which further drives their popularity among pet owners.

Competition Landscape

The pet allergy treatment industry is highly fragmented, with several competitors offering products and services locally. These businesses are using strategies such as business expansion and innovation to meet patients’ demands and grow their customer base.

  • In July 2023, Zoetis Inc. was named the Best Workplace for Innovators by Fast Company for the company’s focus on expanding operations and fostering an innovation culture.
  • In July 2023, Boehringer Ingelheim won the Brand of the Year award for FRONTLINE® for the third consecutive year, showcasing its dedication to pet owners and animals. The company offers innovative products and services for companion animal and livestock health.

Similarly, the team at Persistence Market Research has tracked recent developments related to companies in the pet allergy treatment market, which are available in the full report.

Pet Allergy Treatment Industry Report Scope

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2017 to 2022
Market Analysis US$ Million for Value
Key Countries Covered
  • United States
  • Canada
  • Brazil
  • Argentina
  • Mexico
  • United Kingdom
  • China
  • Italy
  • France
  • Spain
  • Russia
  • Benelux
  • India
  • Indonesia
  • Thailand
  • Philippines
  • Malaysia
  • Vietnam
  • India
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • GCC Countries
  • Türkiye
  • Egypt
  • Israel
  • South Africa
  • Northern Africa
Key Market Segments Covered
  • Drug Class
  • Indication
  • Pet Type
  • Route of Administration
  • Distribution Channel
  • Region
Key Companies Covered
  • Zoetis Animal Healthcare
  • Merck and Co Inc.
  • Boehringer Ingelheim GmbH
  • Elanco Animal Health Incorporated
  • Bayer AG
  • Vetoquinol S.A.
  • Dechra Pharmaceuticals PLC
  • Virbac SA
  • IDEXX Laboratories, Inc.
  • Ceva Santé Animale
  • Kindred Biosciences, Inc.
  • Phirbo Animal Health
  • Norbrook Laboratories Limited
  • Vetiquinol SA
  • Neogen Corporation
  • PetIQ, Inc.
  • Huvepharma AD
  • Chanelle Pharma Group Limited
  • Kepro
  • Biogénesis Bagó
Report Coverage
  • Market Forecast
  • Competition Intelligence
  • DROT Analysis
  • Market Dynamics and Challenges
  • Strategic Growth Initiatives
Customization & Pricing Available upon Request

Key Segments of Pet Allergy Treatment Industry Research

By Drug Class:

  • Antihistamines
  • Corticosteroids
  • Immunotherapy
  • Antibiotics

By Indication:

  • Allergic Dermatitis
  • Food Allergy
  • Fleabite Allergy
  • Contact Allergy

By Pet Type:

  • Dogs
  • Cats
  • Rodents & Rabbits

By Route of Administration:

  • Oral
  • Injectable
  • Topical

By Distribution Channel:

  • Veterinary Hospitals
  • Retail Pharmacies
  • Online Pharmacies
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

- Companies Covered in This Report -

  • Zoetis Animal Healthcare
  • Merck and Co.Inc. (US)
  • Boehringer Ingelheim GmbH
  • Elanco Animal Health Incorporated
  • Bayer AG
  • Vetoquinol S.A.
  • Dechra Pharmaceuticals PLC
  • Virbac SA
  • IDEXX Laboratories, Inc.
  • Ceva Santé Animale
  • Kindred Biosciences, Inc.
  • Phirbo Animal Health
  • Norbrook Laboratories Limited
  • Vetiquinol SA
  • Neogen Corporation
  • PetIQ, Inc.
  • Huvepharma AD
  • Chanelle Pharma Group Limited
  • Kepro
  • Biogénesis Bagó

- Frequently Asked Questions -

The global pet allergy treatment market was valued at US$ 2.1 billion in 2022.

Demand for pet allergy treatment increased at 5.1% CAGR from 2017 to 2022.

The United States accounted for 30.9% share of the global market in 2022.

Germany held 7% share of the global market in 2022.

The market in China reached a value of US$ 161.8 million in 2022.

Antibiotics held a leading market share of 34.8% in 2022.

The United States, China, Germany, the United Kingdom, and Japan together account for 57% market share.

The market for pet allergy treatment is projected to reach US$ 4.1 billion by the end of 2033.

Worldwide revenue from pet allergy treatment is expected to increase at 6.3% CAGR through 2033.

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy
Google translate